Valuation: CVRx, Inc.

Market Cap 37.3M 33.41M 30.82M 27.89M 52.15M 3.55B 53M 368M 147M 1.86B 140M 137M 5.89B P/E 2026 *
-0.7x
P/E 2027 * -0.73x
Enterprise Value 47.8M 42.82M 39.5M 35.74M 66.84M 4.55B 67.92M 471M 188M 2.38B 179M 176M 7.55B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 1.21x
Free-Float
85.05%
Yield 2026 *
-
Yield 2027 * -
1 week+3.28%
Current month-19.14%
1 month-46.20%
3 months-71.41%
6 months-79.40%
Current year-80.07%
1 week 1.28
Extreme 1.28
1.49
1 month 1.26
Extreme 1.255
2.65
Current year 1.26
Extreme 1.255
9.84
1 year 1.26
Extreme 1.255
11.3
3 years 1.26
Extreme 1.255
33.14
5 years 1.26
Extreme 1.255
33.14
10 years 1.26
Extreme 1.255
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 54 12/10/2026
Director of Finance/CFO 43 01/10/2020
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/8/26 Buy

Chief Operating Officer

26,223 0.0988%
12/8/26 Sell

Chief Operating Officer

-1,309 0.0049%
1/6/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.28%-86.91%-89.04% 37.3M
+1.59%+1.58%-16.31%+11.97% 178B
+2.26%+0.99%-16.09%+18.11% 117B
+2.43%+0.29%+5.60%+38.45% 116B
+0.28%+0.59%-44.02%+5.89% 91.03B
+1.57%-3.00%-1.45%+77.08% 61.89B
-0.32%-0.66%+10.51%+81.65% 55.85B
+1.47%-1.43%+8.84%-21.32% 53.16B
+2.19%+1.31%-8.52%+44.86% 44.35B
+1.94%+1.59%-1.11%-6.97% 33.59B
Average +1.35%+1.07%-14.95%+16.07% 75.01B
Weighted average by Cap. +1.59%+1.25%-10.11%+25.57%

Financials

2026 *2027 *
Net sales 58.85M 52.71M 48.63M 44.01M 82.29M 5.6B 83.62M 580M 231M 2.93B 221M 216M 9.29B 66.18M 59.28M 54.69M 49.49M 92.54M 6.3B 94.04M 652M 260M 3.3B 248M 243M 10.45B
Net income -53.45M -47.88M -44.17M -39.97M -74.74M -5.09B -75.95M -527M -210M -2.66B -201M -196M -8.44B -52.14M -46.7M -43.08M -38.99M -72.9M -4.96B -74.08M -514M -205M -2.6B -196M -191M -8.23B
Net Debt 10.5M 9.41M 8.68M 7.85M 14.69M 1B 14.92M 104M 41.31M 523M 39.42M 38.58M 1.66B 42.94M 38.46M 35.48M 32.11M 60.04M 4.09B 61.01M 423M 169M 2.14B 161M 158M 6.78B
Projected Income Statement - Annual - CVRx, Inc.
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
30/10/26 USD 1.415 +1.07% 176,800
28/10/26 USD 1.400 -1.06% 822,349
27/10/26 USD 1.415 -2.41% 447,302
26/10/26 USD 1.450 +2.11% 224,026
23/10/26 USD 1.420 +3.65% 199,851
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CVRx, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.400USD
Average target price
4.583USD
Spread / Average Target
+227.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CVRx, Inc.
  1. Stock Market
  2. Stocks
  3. CVRX Stock